SLC45A3 Antikörper
-
- Target Alle SLC45A3 Produkte
- SLC45A3 (Solute Carrier Family 45, Member 3 (SLC45A3))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SLC45A3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human SLC45A3
- Isotyp
- IgG
-
-
- Applikationshinweise
- WB 1:200-1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.7 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- SLC45A3 (Solute Carrier Family 45, Member 3 (SLC45A3))
- Andere Bezeichnung
- SLC45A3 (SLC45A3 Produkte)
- Hintergrund
- Solute carrier family 45 member 3(SLC45A3), also known asprostate cancer-associated protein 6orprostein, is aproteinthat in humans is encoded by theSLC45A3gene. SLC45A3 is expressed in a prostate-specific manner by normal tissues and at a significantly lower level in prostate tumor cell lines. Treatment prostate cancer cell lines with androgens upregulates the expression of SLC45A3.
- Molekulargewicht
- 59 kDa
- NCBI Accession
- NP_149093
- UniProt
- Q96JT2
-